Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Biological intratumoral therapy for the high-grade glioma part I: intratumoral delivery and immunotoxins.

Loya J, Zhang C, Cox E, Achrol AS, Kesari S.

CNS Oncol. 2019 Nov 1;8(3):CNS38. doi: 10.2217/cns-2019-0001. Epub 2019 Nov 21.

2.

Biological intratumoral therapy for the high-grade glioma part II: vector- and cell-based therapies and radioimmunotherapy.

Loya J, Zhang C, Cox E, Achrol AS, Kesari S.

CNS Oncol. 2019 Nov 1;8(3):CNS40. doi: 10.2217/cns-2019-0002. Epub 2019 Nov 21.

3.

Adults with newly diagnosed high-grade gliomas.

Croteau D, Mikkelsen T.

Curr Treat Options Oncol. 2001 Dec;2(6):507-15. Review.

PMID:
12057096
4.

New therapeutic approaches for malignant glioma: in search of the Rosetta stone.

Auffinger B, Thaci B, Nigam P, Rincon E, Cheng Y, Lesniak MS.

F1000 Med Rep. 2012;4:18. Epub 2012 Sep 5.

5.

A novel bispecific immunotoxin delivered by human bone marrow-derived mesenchymal stem cells to target blood vessels and vasculogenic mimicry of malignant gliomas.

Zhang Y, Sun X, Huang M, Ke Y, Wang J, Liu X.

Drug Des Devel Ther. 2015 Jun 11;9:2947-59. doi: 10.2147/DDDT.S79475. eCollection 2015.

6.

Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.

van Tellingen O, Yetkin-Arik B, de Gooijer MC, Wesseling P, Wurdinger T, de Vries HE.

Drug Resist Updat. 2015 Mar;19:1-12. doi: 10.1016/j.drup.2015.02.002. Epub 2015 Mar 6. Review.

PMID:
25791797
7.

Intratumoral cancer chemotherapy and immunotherapy: opportunities for nonsystemic preoperative drug delivery.

Goldberg EP, Hadba AR, Almond BA, Marotta JS.

J Pharm Pharmacol. 2002 Feb;54(2):159-80. Review.

PMID:
11848280
8.

Intratumoral immunotoxin treatment of human malignant brain tumors in immunodeficient animals.

Engebraaten O, Hjortland GO, Juell S, Hirschberg H, Fodstad O.

Int J Cancer. 2002 Feb 20;97(6):846-52.

9.

Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.

Chen R, Cohen AL, Colman H.

Curr Treat Options Oncol. 2016 Aug;17(8):42. doi: 10.1007/s11864-016-0418-0. Review.

PMID:
27334978
10.

Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.

Lefranc F, Rynkowski M, DeWitte O, Kiss R.

Adv Tech Stand Neurosurg. 2009;34:3-35. Review.

PMID:
19368079
11.

Embryonic stem cell (ESC)-mediated transgene delivery induces growth suppression, apoptosis and radiosensitization, and overcomes temozolomide resistance in malignant gliomas.

Germano IM, Emdad L, Qadeer ZA, Binello E, Uzzaman M.

Cancer Gene Ther. 2010 Sep;17(9):664-74. doi: 10.1038/cgt.2010.31. Epub 2010 Jun 4.

12.

Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.

Hargrave D.

Br J Neurosurg. 2009 Aug;23(4):351-63. doi: 10.1080/02688690903158809. Review.

PMID:
19637006
13.

Anti-angiogenic therapy for high-grade glioma.

Ameratunga M, Pavlakis N, Wheeler H, Grant R, Simes J, Khasraw M.

Cochrane Database Syst Rev. 2018 Nov 22;11:CD008218. doi: 10.1002/14651858.CD008218.pub4.

14.

Molecular and cellular intratumoral heterogeneity in primary glioblastoma: clinical and translational implications.

Bernstock JD, Mooney JH, Ilyas A, Chagoya G, Estevez-Ordonez D, Ibrahim A, Nakano I.

J Neurosurg. 2019 Aug 23:1-9. doi: 10.3171/2019.5.JNS19364. [Epub ahead of print] Review.

PMID:
31443071
15.

Novel chemotherapeutics and other therapies for treating high-grade glioma.

Kang JH, Adamson C.

Expert Opin Investig Drugs. 2015;24(10):1361-79. doi: 10.1517/13543784.2015.1048332. Epub 2015 Aug 14. Review.

PMID:
26289791
16.

Novel drug delivery strategies in neuro-oncology.

Bidros DS, Vogelbaum MA.

Neurotherapeutics. 2009 Jul;6(3):539-46. doi: 10.1016/j.nurt.2009.04.004. Review.

17.

High-grade gliomas: reality and hopes.

Mirimanoff RO.

Chin J Cancer. 2014 Jan;33(1):1-3. doi: 10.5732/cjc.013.10215.

18.

High-grade gliomas.

de Groot JF.

Continuum (Minneap Minn). 2015 Apr;21(2 Neuro-oncology):332-44. doi: 10.1212/01.CON.0000464173.58262.d9. Review.

PMID:
25837899
19.

Current status of intratumoral therapy for glioblastoma.

Mehta AI, Linninger A, Lesniak MS, Engelhard HH.

J Neurooncol. 2015 Oct;125(1):1-7. doi: 10.1007/s11060-015-1875-1. Epub 2015 Aug 2.

PMID:
26233248
20.

Intratumoral chemotherapy.

Walter KA, Tamargo RJ, Olivi A, Burger PC, Brem H.

Neurosurgery. 1995 Dec;37(6):1128-45. Review.

PMID:
8584154

Supplemental Content

Support Center